SB Bioseutica OVOTRANSFERRIN

BIOSEUTICA BV has been created in 2008 after the merger of Neova Technologies Inc. and KD-PHARMA GmbH. In 2013 a majority stake of KD-PHARMA GmbH has been sold to a german private equity.

Bioseutica’s subsidiaries, Fordras SA, Neova Technologies Inc. and Bioseutica BV are experts in the extraction and purification of egg proteins which form the Lysozyme and Ovoproducts division.

Eggs are a rich natural source of proteins with diverse properties and functionality. All proteins in an egg work together to ensure supply of the developing chicken with nutrients for growths and to ensure protection from pathogens such as bacteria or viruses. 

Lysozyme and our other Ovoproteins are extracted from naturally occurring hen egg-white, a non-GMO and renewable protein source.